Association of Serum Ustekinumab Levels With Clinical Response in Psoriasis | Zendy

Teresa Tsakok | Zendy; Nina Wilson | Zendy; Nick Dand | Zendy; Floris C. Loeff | Zendy; Karien Bloem | Zendy; David Baudry | Zendy; Michael Duckworth | Zendy; Shan Pan | Zendy; Angela Pushpa-Rajah | Zendy; Joseph F. Standing | Zendy; Annick de Vries | Zendy; Ali Alsharqi | Zendy; G Becher | Zendy; Ruth Murphy | Zendy; Shyamal Wahie | Zendy; Andrew Wright | Zendy; C.E.M. Griffiths | Zendy; Nick J. Reynolds | Zendy; Juliet N. Barker | Zendy; Richard B. Warren | Zendy; A. David Burden | Zendy; Theo Rispens | Zendy; Deborah Stocken | Zendy; Catherine Smith | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Association of Serum Ustekinumab Levels With Clinical Response in Psoriasis

Author(s) -

Teresa Tsakok,

Nina Wilson,

Nick Dand,

Floris C. Loeff,

Karien Bloem,

David Baudry,

Michael Duckworth,

Shan Pan,

Angela Pushpa-Rajah,

Joseph F. Standing,

Annick de Vries,

Ali Alsharqi,

G Becher,

Ruth Murphy,

Shyamal Wahie,

Andrew Wright,

C.E.M. Griffiths,

Nick J. Reynolds,

Juliet N. Barker,

Richard B. Warren,

A. David Burden,

Theo Rispens,

Deborah Stocken,

Catherine Smith

Publication year - 2019

Publication title -

jama dermatology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.128

H-Index - 166

eISSN - 2168-6084

pISSN - 2168-6068

DOI - 10.1001/jamadermatol.2019.1783

Subject(s) - medicine , ustekinumab , psoriasis , psoriasis area and severity index , observational study , dosing , clinical endpoint , prospective cohort study , clinical trial , immunology , disease , adalimumab

High-cost biologic therapies have transformed the management of immune-mediated inflammatory diseases. To optimize outcomes and reduce costs, dose adjustment informed by measurement of circulating drug levels has been shown to be effective in various settings. However, limited evidence exists for this approach with the interleukin 12 and interleukin 23 inhibitor ustekinumab.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research